ArticleInternational journal of hematology2026

Letter comments on: "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".

Rajesh Prasad Jayaswal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.